ReviewInternational journal of molecular sciences2023

Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk.

Alessia d'Aiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.